US Patent 9173929 Mucinous glycoprotein (MUC-1) vaccine

Patent 9173929 was granted and assigned to Oncothyreon on November, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Oncothyreon

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

91739290

Date of Patent

November 3, 2015

Patent Application Number

105949920

Date Filed

April 1, 2005

Patent Primary Examiner

‌

Mark Halvorson

Patent abstract

The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.